MLAB Valuation

Mesa Laboratories Inc

Add to Watchlist

Advanced Chart

77.260

+1.64(2.169%)1D

Overview
Forecast
Valuation
Earnings

MLAB Relative Valuation

MLAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MLAB is overvalued; if below, it's undervalued.

Historical Valuation

Mesa Laboratories Inc (MLAB) is now in the Fair zone, suggesting that its current forward PE ratio of 43.13 is considered Fairly compared with the five-year average of 31.08. The fair price of Mesa Laboratories Inc (MLAB) is between 53.83 to 96.52 according to relative valuation methord.

Relative Value

Fair Zone

53.83-96.52

Current Price：77.34

Fair

44.15

Trailing

Forward

9.83

EV/EBITDA

Mesa Laboratories Inc. (MLAB) has a current EV/EBITDA of 9.83. The 5-year average EV/EBITDA is 21.26. The thresholds are as follows: Strongly Undervalued below 7.16, Undervalued between 7.16 and 14.21, Fairly Valued between 28.32 and 14.21, Overvalued between 28.32 and 35.37, and Strongly Overvalued above 35.37. The current Forward EV/EBITDA of 9.83 falls within the Undervalued range.

9.96

EV/EBIT

Mesa Laboratories Inc. (MLAB) has a current EV/EBIT of 9.96. The 5-year average EV/EBIT is 24.99. The thresholds are as follows: Strongly Undervalued below -0.79, Undervalued between -0.79 and 12.10, Fairly Valued between 37.87 and 12.10, Overvalued between 37.87 and 50.76, and Strongly Overvalued above 50.76. The current Forward EV/EBIT of 9.96 falls within the Undervalued range.

1.65

Mesa Laboratories Inc. (MLAB) has a current PS of 1.65. The 5-year average PS is 4.99. The thresholds are as follows: Strongly Undervalued below -0.48, Undervalued between -0.48 and 2.25, Fairly Valued between 7.73 and 2.25, Overvalued between 7.73 and 10.47, and Strongly Overvalued above 10.47. The current Forward PS of 1.65 falls within the Undervalued range.

9.86

P/OCF

Mesa Laboratories Inc. (MLAB) has a current P/OCF of 9.86. The 5-year average P/OCF is 23.43. The thresholds are as follows: Strongly Undervalued below -1.04, Undervalued between -1.04 and 11.20, Fairly Valued between 35.67 and 11.20, Overvalued between 35.67 and 47.91, and Strongly Overvalued above 47.91. The current Forward P/OCF of 9.86 falls within the Undervalued range.

11.12

P/FCF

Mesa Laboratories Inc. (MLAB) has a current P/FCF of 11.12. The 5-year average P/FCF is 26.42. The thresholds are as follows: Strongly Undervalued below -1.23, Undervalued between -1.23 and 12.60, Fairly Valued between 40.25 and 12.60, Overvalued between 40.25 and 54.08, and Strongly Overvalued above 54.08. The current Forward P/FCF of 11.12 falls within the Undervalued range.

Mesa Laboratories Inc (MLAB) has a current Price-to-Book (P/B) ratio of 2.58. Compared to its 3-year average P/B ratio of 2.87 , the current P/B ratio is approximately -10.19% higher. Relative to its 5-year average P/B ratio of 3.11, the current P/B ratio is about -17.03% higher. Mesa Laboratories Inc (MLAB) has a Forward Free Cash Flow (FCF) yield of approximately 10.41%. Compared to its 3-year average FCF yield of 5.45%, the current FCF yield is approximately 91.04% lower. Relative to its 5-year average FCF yield of 4.26% , the current FCF yield is about 144.44% lower.

2.64

P/B

Median3y

2.87

Median5y

3.11

10.23

FCF Yield

Median3y

5.45

Median5y

4.26

Competitors Valuation Multiple

The average P/S ratio for MLAB's competitors is 1.47, providing a benchmark for relative valuation. Mesa Laboratories Inc Corp (MLAB) exhibits a P/S ratio of 1.65, which is 12.29% above the industry average. Given its robust revenue growth of 5.49%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

MLAB.O

Mesa Laboratories Inc

AirSculpt Technologies Inc

Performance Decomposition

Market capitalization of MLAB decreased by 32.46% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -133.36 to -212.58.

The secondary factor is the Revenue Growth, contributed 5.49%to the performance.

Overall, the performance of MLAB in the past 1 year is driven by P/E Change. Which is more unsustainable.

5.49%

58.90M → 62.14M

Revenue Growth

-97.35%

-432.20 → -11.45

Margin Expansion

59.40%

-133.36 → -212.58

P/E Change

-32.46%